Search

Your search keyword '"Condliffe, R."' showing total 324 results

Search Constraints

Start Over You searched for: Author "Condliffe, R." Remove constraint Author: "Condliffe, R."
324 results on '"Condliffe, R."'

Search Results

1. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

3. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

7. Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH (REPEAT-PAH)

8. Systematic Follow-up of Patients Following Acute Pulmonary Embolism Identifies High Incidence of Chronic Thromboembolic Pulmonary Hypertension: ASPIRE CTEPH

10. P81 Effect of COVID-19 infection and preventive public health measures on haemodynamics, activity and quality of life in patients with pulmonary arterial hypertension

12. S92 Remote monitoring enabled evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension

13. S91 Remote monitored physical activity is related to established measures of clinical risk in patients with pulmonary arterial hypertension

14. S90 Right ventricular remodelling assessed using cardiac magnetic resonance predicts survival and treatment response in pulmonary arterial hypertension

15. S93 Systematic follow-up of patients following acute pulmonary embolism is associated with an increased incidence of chronic thromboembolic pulmonary hypertension and less severe disease

16. P39 Establishing minimally important differences for cardiac MRI endpoints in pulmonary arterial hypertension

17. P38 Assessing the repeatability of NT-proBNP testing using laboratory and point of care testing in PAH (REPEAT-PAH)

20. Baseline characteristics of patients included into the ERS Clinical Research Collaboration: “Pulmonary Hemodynamics during Exercise - Research Network” (PEX-NET) registry

22. Fully automatic deep learning pulmonary hypertension diagnosis using CT pulmonary angiography

25. CMR assessed maladaptive right ventricular remodelling predicts treatment failure in pulmonary arterial hypertension

27. Impact of patient choice on survival in patients with chronic thromboembolic pulmonary hypertension offered pulmonary endarterectomy: P183

31. Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension

32. Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response

33. Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension

34. Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements

35. Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT

36. Elective lower limb orthopaedic arthroplasty surgery in patients with pulmonary hypertension

37. CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension

38. Baseline characteristics of patients included into the ERS Clinical Research Collaboration: Pulmonary Hemodynamics during Exercise - Research Network (PEX-NET) registry

39. Training and Clinical Validation of Artificial Intelligence Derived Right Atrial Cardiovascular Magnetic Resonance Measurements

41. Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood

42. Use of pulmonary arterial hypertension therapies in Fontan patients: current practice across the United Kingdom

43. Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy

44. Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction

45. EXPRESS: Positioning Imatinib for Pulmonary Arterial Hypertension (PIPAH): A phase I/II design comprising dose finding and single arm efficacy Short title: Imatinib for PAH

49. Cardiac-MRI predicts clinical worsening and mortality in pulmonary arterial hypertension: a systematic review and meta-analysis

50. Pulmonary hypertension in association with lung disease : quantitative CT and artificial intelligence to the rescue? State-of-the-art review

Catalog

Books, media, physical & digital resources